Notably, there were no significant differences in exhausted (PD-1+) or late-activated CD4+ or CD8+ T cells between the two groups in the clinical cohort (p > 0.05), indicating that the T cell abnormalities in DCM patients may be driven predominantly by early activation rather than terminal exhaustion. This evidence concerns the gene CD4 and familial dilated cardiomyopathy.